Next Article in Journal
Immune Checkpoint Inhibitor Combination Therapy versus Sunitinib as First-Line Treatment for Favorable-IMDC-Risk Advanced Renal Cell Carcinoma Patients: A Meta-Analysis of Randomized Clinical Trials
Next Article in Special Issue
Metal-Based Complexes in Cancer Treatment
Previous Article in Journal
Plant Secondary Metabolites Used for the Treatment of Diseases and Drug Development
Previous Article in Special Issue
Synthesis, Structure, and Antiproliferative Action of 2-Pyridyl Urea-Based Cu(II) Complexes
 
 
Review

Article Versions Notes

Biomedicines 2022, 10(3), 578; https://doi.org/10.3390/biomedicines10030578
Action Date Notes Link
article pdf uploaded. 1 March 2022 13:47 CET Version of Record https://www.mdpi.com/2227-9059/10/3/578/pdf-vor
article supplementary file uploaded. 1 March 2022 13:47 CET - https://www.mdpi.com/2227-9059/10/3/578#supplementary
article xml file uploaded 2 March 2022 10:22 CET Original file -
article xml uploaded. 2 March 2022 10:22 CET Update https://www.mdpi.com/2227-9059/10/3/578/xml
article pdf uploaded. 2 March 2022 10:22 CET Updated version of record https://www.mdpi.com/2227-9059/10/3/578/pdf
article html file updated 2 March 2022 10:34 CET Original file -
article html file updated 3 March 2022 10:04 CET Update -
article html file updated 1 August 2022 03:34 CEST Update https://www.mdpi.com/2227-9059/10/3/578/html
Back to TopTop